NCT04458259 2025-08-28Study of PF-07265807 in Participants With Metastatic Solid Tumors.PfizerPhase 1 Terminated88 enrolled
NCT00094107 2012-06-26Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic MelanomaPfizerPhase 2 Completed32 enrolled 9 charts